SNGX
Soligenix Inc.
NASDAQ: SNGX · HEALTHCARE · BIOTECHNOLOGY
$0.35
+2.07% today
Updated 2026-04-30
Market cap
$4.34M
P/E ratio
—
P/S ratio
9.78x
EPS (TTM)
$-2.14
Dividend yield
—
52W range
$0 – $6
Volume
0.6M
WallStSmart proprietary scores
19
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$15.00
+4247.83%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.75M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $250000.00 | $839359.00 | $119371.00 | $0.00 | $0.00 |
| Net income | $-13.80M | $-6.14M | $-8.27M | $-11.08M | $-2.90M |
| EPS | — | — | — | — | $-2.14 |
| Free cash flow | $-12.66M | $-8.60M | $-8.40M | $-10.27M | $-2.75M |
| Profit margin | -5,519.34% | -731.60% | -6,925.11% | — | — |
Peer comparison
Smart narrative
Soligenix Inc. trades at $0.35. Our Smart Value Score of 19/100 indicates the stock is weak.
Frequently asked questions
What is Soligenix Inc.'s stock price?
Soligenix Inc. (SNGX) trades at $0.35.
Is Soligenix Inc. overvalued?
Smart Value Score 19/100 (Grade F, Strong Sell).
What is the price target of Soligenix Inc. (SNGX)?
The analyst target price is $15.00, representing +4247.8% upside from the current price of $0.35.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio9.78x
ROE-235.50%
Beta1.94
50D MA$1.18
200D MA$1.65
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—